An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

University of Rochester41 enrolled

Overview

This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies

Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with hematologic malignancies, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Hematologic Malignancies

Interventions

Inpatient serious illness care programBEHAVIORAL

Inpatient advance care planning intervention that will be delivered by advanced care practitioners or hematology/oncology fellow physicians. The intervention will be an adapted version of the serious illness care program.

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥60 years * A diagnosis of hematologic malignancy \[including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment\] * Able to provide informed consent * Being managed in the inpatient setting * English-speaking Exclusion Criteria: • None

Locations (1)

University of Rochester

Rochester, New York, United States

Outcomes

Primary Outcomes

Retention Rate

Retention rate is the percentage of consented patients who completed the ACP intervention visit. A retention rate of \>70% was considered feasible.

Time frame: From consent until completion of the ACP intervention visit, usually within 1 week.

Secondary Outcomes

Advance Directive Completion - HCP

Data on the patient's completion of scanned healthcare proxy form that was completed with their physician was collected via the electronic medical record. This is expressed as a percentage.

Time frame: From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.

Advance Directive Completion - MOLST

Data on the patient's completion of scanned medical order for life sustaining treatment (MOLST) form that was completed with their clinician was collected via the electronic medical record. This is expressed as a percentage.

Time frame: From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.